JBM (Healthcare) Limited (2161.HK)

HKD 2.09

(6.09%)

Revenue Summary of JBM (Healthcare) Limited

  • JBM (Healthcare) Limited's latest annual revenue in 2023 was 648.41 Million HKD , up 24.62% from previous year.
  • JBM (Healthcare) Limited's latest quarterly revenue in 2023 FY was 648.41 Million HKD , up 24.62% from previous quarter.
  • JBM (Healthcare) Limited reported a annual revenue of 520.32 Million HKD in annual revenue 2022, up 28.11% from previous year.
  • JBM (Healthcare) Limited reported a annual revenue of 406.13 Million HKD in annual revenue 2021, up 2.26% from previous year.
  • JBM (Healthcare) Limited reported a quarterly revenue of 648.41 Million HKD for 2023 FY, up 24.62% from previous quarter.
  • JBM (Healthcare) Limited reported a quarterly revenue of 321.58 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of JBM (Healthcare) Limited (2023 - 2017)

Historical Annual Revenue of JBM (Healthcare) Limited (2023 - 2017)

Year Revenue Revenue Growth
2023 648.41 Million HKD 24.62%
2022 520.32 Million HKD 28.11%
2021 406.13 Million HKD 2.26%
2020 397.15 Million HKD 4.09%
2019 381.54 Million HKD 24.07%
2018 307.51 Million HKD 16.34%
2017 264.33 Million HKD 0.0%

Peer Revenue Comparison of JBM (Healthcare) Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD -150.201%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 93.842%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -997.186%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD 17.281%
Qianhai Health Holdings Limited 961.29 Million HKD 32.547%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD 38.424%
Essex Bio-Technology Limited 1.7 Billion HKD 62.004%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD 19.86%
PuraPharm Corporation Limited 406.85 Million HKD -59.371%
SSY Group Limited 6.46 Billion HKD 89.967%
Jacobson Pharma Corporation Limited 1.46 Billion HKD 55.824%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.76%